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Quantitation and Visualization of
Alkyl Deoxynucleosides in the DNA of
Mammalian Cells by Monoclonal Antibodies
by Jurgen Adamkiewicz,* Gertrude Eberle,* Namho Huh,*
Peter Nehis,* and Manfred F. Rajewsky*t
Conventional radiochromatographic procedures for the quantitation of carcinogen/mutagen-induced
structural DNA modifications have a number of limitations. Thus, these techniques for the most part
require application of radioactively labeled carcinogens and the use of relatively large amounts of DNA
for analysis at low levels of DNA modification. Radiochromatographic methods also preclude analyses at
the level ofsingle cells and DNA molecules. Recently developed immunoanalytical methods have improved
this situation considerably. Monoclonal antibodies (Mab) characterized by a high substrate specificity and
affinity, in combination with radio- and enzyme-immunoassays, or with "immuno-slot-blot" techniques,
now permit the detection offemtomole to subfemtomole amounts of, e.g., alkyldeoxynucleosides in small
samples of DNA isolated from tissues or cultured cells previously exposed to nonradioactive N-nitroso
compounds. Furthermore, selected Mab can be used to quantitate by direct immunofluorescence (with the
aid of computer-based image analysis of electronically intensified fluorescence signals), specific alkyl-
deoxynucleosides inthenuclearDNAofsinglecells. Withthismethod, thedetectionlimitforthealkylation
product 0'-ethyldeoxyguanosine (06-EtdGuo) is presently of the order of W-103 06-EtdGuo residues per
diploid mammalian genome. Individual cells canthus bemonitoredforthepresence ofspecific carcinogen-
DNA adducts, and with respect to their capacity for enzymatic removal of such modified structures from
DNA (as exemplified here by the kinetics of the enzymatic elimination of 06-EtdGuo from the DNA of
malignant neurogenic rat cell lines). In combination with transmission electron microscopy, Mab also
permit direct visualization (via Mab binding sites) ofspecific carcinogen-modified structures in individual
DNA molecules. DNA strands of defined nucleotide sequence can thus be analyzed by immuno-electron
microscopy for the presence of"hot spots" ofspecific structural alterations caused by defined carcinogens/
mutagens.
Introduction
The sensitive detection and quantitation of defined
reaction products of chemical carcinogens, mutagens,
or chemotherapeutic agents, with target cell DNA rep-
resents an obligatory requirement for analysis of the
genetic consequences of specific alterations of DNA
structure, for measurements ofcellular DNA repair ca-
pacity, and forbiological dosimetry and risk estimation.
Conventional radiochromatographic procedures for an-
alysis of chemically modified DNA have a number of
limitations. Thus, withthe exception of32P-postlabeling
methods (1,2), these techniques require application of
radioactively labeled (i.e., laboratory-synthesized) DNA-
reactive agents, and the use ofrelatively large amounts
of DNA (cells) for analysis at low levels of DNA mod-
ification (3,4). This situation has been improved consid-
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erably by the recent introduction of immunoanalytical
methods, notably those based on the use ofmonoclonal
antibodies (Mab) (5-16). Selected high-affinity Mab can
now be used for the sensitive and specific recognition
and quantitation ofDNA components structurally mod-
ified by nonradioactive (e.g., environmental) agents.
While other laboratories have focused on the produc-
tion of antisera, and in some cases of Mab, directed
against DNA components structurally altered by re-
action with aflatoxin B1, N-2-acetylaminofluorene, or
benzo(a)pyrene (7,9,12-15), ourgrouphasconcentrated
on the development of Mab specific for alkyldeoxynu-
cleosides produced in cellular DNA by alkylating N-
nitroso compounds (5,6,11,17-26). We have thus ex-
ploited the exceptional capability of antibodies to rec-
ognizesubtlealterationsofmolecularstructure, inorder
to distinguish deoxynucleosides modified by the cova-
lent attachment of single, small alkyl groups (methyl,
ethyl, butyl, isopropyl) from their normal, unaltered
counterparts. The results thus far obtained with this
approach have been most encouraging. Mab with very
high affinity and specificity for the respective alkyl-ADAMKIEWICZ ET AL.
deoxynucleosides were obtained by immunization with
alkylribonucleosides as haptens coupled to keyhole lim-
pet hemocyanin (KLH) as a carrier protein (5,6,22).
With the use of different immunoanalytical methods,
specific alkyldeoxynucleosides can now be quantitated
with high sensitivity in small amounts of DNA or in
DNAhydrolyzed tomonodeoxynucleosides, inthe DNA
of individual cells, and in single DNA molecules
(19,21,22,24-26). Inthepresentreport, we describethe
properties ofMab specific forthe DNA alkylation prod-
ucts 06-methyldeoxyguanosine (06-MedGuo), O6-
ethyldeoxyguanosine (06-EtdGuo), 06-butyldeoxy-
guanosine (06-BudGuo), 06-isopropyldeoxyguanosine
(06-iProdGuo), 04-methyldeoxythymidine (04-MedThd),
and 04-ethyldeoxythymidine (04-EtdThd). In addition,
the principles as well as the particular advantages of
different types ofimmunoassays will be compared, and
an example will be presented showing the application
ofacompetitiveradioimmunoassay (RIA)formeasuring
the kinetics ofthe enzymatic elimination of06-EtdGuo
from the DNA ofa number ofmalignant neural rat cell
lines.
Immunoanalytical Methods Using
Anti-Alkyldeoxynucleoside
Antibodies
Production and Characterization ofAnti-
Alkyldeoxynucleoside Monoclonal
Antibodies (Mab)
For immunization, alkylribonucleosides (haptens) were
coupled to the carrier protein keyhole limpet hemocy-
anin (KLH; Calbiochem, Marburg, Germany) (5,22,27).
Adult female rats of the inbred BDIX strain (28), or
adult female Balb/c mice, were immunized by intracu-
taneous injections of the immunogen emulsified in alu-
minium hydroxide (Alugel S; Serva, Heidelberg,
Germany) and Freund's adjuvant (Behring-Werke,
Marburg, Germany), following published procedures
(5,22). Spleen cellsisolated fromthe immunized animals
were fused with cells of the mouse myeloma cell line
P3-X63-Ag8.653 (29) or with cells of the rat myeloma
celllineX3-Agl.2.3 (30), respectively, polyethylenegly-
col (PEG 4000; Roth, Karlsruhe, Germany) being used
as the fusion reagent (5,6). Hybridoma cell cultures se-
creting anti-alkyldeoxynucleoside Mab were identified
with the aid of an enzyme immunoassay (6) or by com-
petitive RIA (see below), and subsequently cloned and
recloned. Positive rat x rat and mouse x mouse hy-
bridoma clones were maintained in cell culture for an-
tibody production. When larger amounts of Mab were
required, hybridoma cells were injected intraperito-
neally eitherintoPristan-pretreated Balb/cmice orinto
Pristan-pretreated, X-irradiated (4 Gy) BDIX-rats for
antibody production into the ascitic fluid (5,6). Mab is-
otype analyses were carried out with the use of anti-
rat isotype antisera (Miles, Frankfurt am Main, Ger-
many) and antimouse isotype antibodies kindly donated
to us by A. Radbruch (Institut fur Genetik, Universitat
Koln, Germany). Antibodyconcentrations incellculture
media or ascitic fluid, and antibody affinity constants
for the respective alkyl-deoxynucleosides, were calcu-
latedfromdataobtainedbycompetitive RIA(31). When
required, Mab were isolated with the aid of specific
hapten-immunosorbents (hapten coupled to epoxy-ac-
tivated Sepharose 6 B; Pharmacia, Uppsala, Sweden)
at acid or alkaline pH (22). The affinity constants ofthe
anti-alkyldeoxynucleoside Mab thus farproduced in our
laboratory range from 3 x 106 to 3 x 1010 L/mole.
Competitive Radioimmunoassay (RIA)
The conditions of the competitive RIA, a modified
Farr assay (32), have previouslybeendescribed (21,22).
A typical RIA sample contains in a total volume of 100
,uLofTris-buffered salinesupplementedwith 1%bovine
serum albumin (w/v) and 0.1% bovine IgG (w/v), -2.5
x 103 dpm of [3H]-labeled tracer, an antibody solution
diluted to give 50% binding of tracer in the absence of
inhibitor, and varying amounts ofinhibitor (i.e., either
alkylated DNA hydrolyzed enzymatically to monode-
oxynucleosides or other natural or modified DNA con-
stituents to be analyzed for cross-reactivity). After in-
cubation at room temperature for 2 hr (equilibrium),
100 ,uL of a saturated ammonium sulfate solution (pH
7.0) are added. After 10 min, the samples are centri-
fuged at 10,000gfor3 min. Thereafter, the [3H]-activity
is measured byliquid scintillation spectrometry in a 150
,uL-aliquot. The degree ofinhibition oftracer-antibody
binding (ITAB) is calculated as described (22). For
quantitation ofunknown amounts of alkyldeoxynucleo-
sides in DNA isolated from tissues or cultured cells,
DNA is hydrolyzed to monodeoxynucleosides with
DNase I (EC 3.1.4.5; Boehringer Mannheim, Mann-
heim, Germany), snake venom phosphodiesterase (EC
3.1.4.1; Boehringer), and alkaline phosphatase (EC
3.1.3.1; Boehringer), as described (22). Concentrations
ofdeoxyguanosine (dGuo) and deoxythymidine, respec-
tively, intheDNAhydrolyzates aredeterminedbypeak
integrationafterseparationbyreverse-phasehighpres-
sure liquid chromatography (HPLC). Antigen concen-
trations in the DNA hydrolyzates are determined by
comparing their ITAB-values with those of standard
curves forthe particularalkyldeoxynucleosides in ques-
tion. Reverse-phase HPLC is also used for separation
of different alkylation products from the same DNA
samplefollowed by concentration ofthe respective frac-
tions by evaporation in a Speed Vac concentrator (Sa-
vant Instruments, Hicksville, NY, USA), prior to their
analysis by RIA (6), (see Fig. 1 and Table 1). Under
these conditions, the sensitivity ofthe competitive RIA
is limited onlybythe total amount ofDNA available for
analysis. Table 1 shows the detection limit and sensi-
tivity ofthe competitive RIA, using selected Mab spe-
cific for dGuo with different alkyl groups covalently
50MONOCLONAL ANTIBODY-BASED IMMUNOANALYSIS
attached to the 06-atom, and for deoxythymidine meth-
ylated or ethylated in the 04-position.
An example ofthe application ofthe competitive RIA
for analysis of alkyldeoxynucleosides in small amounts
ofDNAis showninFigure 2. ByusingMab ER-6 (Table
1), the capacity for enzymatic removal of 06-EtdGuo
from DNA was determined in a number of cultured
malignant neuroectodermal cell lines (BT- and V-lines)
induced byinvivo exposure offetal ratbraincells (FBC)
to the N-nitroso carcinogen N-ethyl-N-nitrosourea
(EtNU) (33-36). Interestingly, these FBC-derived ma-
lignant cell lines remove 06-EtdGuo from their DNA
very efficiently; in fact, more efficiently than rat liver,
which among normal rat tissues is characterized by the
highest capacity for enzymatic removal of 06-EtdGuo
(34,37). The BT- and V-lines originate from BDIX-rat
FBC (18th day ofprenatal development), and have either
undergone tumorigenic conversion in cell culture after
exposuretoEtNU invivo (BT-lines) or are derived from
neural tumors that had developed in vivo after prenatal
exposure to EtNU (V-lines) (33,34,38). Both pre- and
postnatal rat brain cells are, however, deficient with
respect to enzymatic removal of 06-alkyldeoxyguano-
sine from DNA (34,37,39). In this cell systemmalignant
transformation (or some as yet undefined stage of the
process ofmalignant conversion preceding the ultimate
development of tumorigenic phenotypes) may, there-
fore, be associated with the activation of 06-alkyldeoxy-
guanosine repair (36). Since the 06-EtdGuo elimination-
proficient, malignant neuroectodermal BT- and V-cells
were maintained and analyzed in cell culture, it will,
however, also be important to test whether the expres-
sion ofDNArepair enzymes maybemodified byinvitro
cultivation of (malignant) cells. The present studies have
also provided information on the stability of the "os-
EtdGuo repair-phenotype" ofthe malignant neurogenic
rat cells (36). Subcloning in semisolid agar medium of
one ofthe repair-proficient clonal BT-lines (BT3Ca) (Fig.
2A) resulted in a panel of eight subclones which, upon
re-analysis by competitive RIA, again exhibited vary-
ingdegrees of06-EtdGuo removal from DNA (Fig. 2B).
This rapid diversification of cellular capacity for O6-
EtdGuo elimination in the course ofthe cell generations
required for subeloning, indicates considerable insta-
bility of the "06-EtdGuo repair phenotype." Malignant
cell subpopulations varyingwith respect to DNArepair
capacity may, therefore, continuously develop in the
course of tumor growth and progression. The implica-
tions of tumor cell heterogeneity in terms of cellular
DNA repair capacity have been discussed elsewhere
(35).
Immuno-Slot-Blot (ISB)
The ISB, anoncompetitive solid-phase immunoassay,
was designed particularly for the quantitation of low
levels of modified deoxynucleosides in very small sam-
ples of DNA, e.g., in DNA contained in small numbers
of cells, in selected fractions of chromatin or in DNA
restriction fragments (26). With the presently available
Mab, the ISB requires single-stranded DNA. Applica-
tion of the ISB is, therefore, restricted to the analysis
of DNA containing modified structures that are stable
duringdenaturationofDNAbyheat oralkalitreatment,
e.g., 06-EtdGuo or 04-EtdThd (26).
For analysis by ISB, samples ofalkylated DNA (< 3
jig of DNA in a volume of 100 ,uL) are heat-denatured
for 10 min, immediately chilled on ice, and mixed with
equal volumes of 2 M ammonium acetate. The single-
stranded DNA is then immobilized on nitrocellulose (NC)
filters (BA 52; Schleicher and Schull, Dassel, Germany)
using a 72-slot Minifold II vacuum filter device
(Schleicher and Schull). The NS filters are presoaked
in 1 M ammonium acetate priorto use. Afterapplication
of DNA, the slots are rinsed with 1 M ammonium ace-
tate (200 puL/slot). Thereafter, the NC filters are soaked
in 5 x SSC (0.75 M NaCl, 0.075 M trisodium citrate)
for 5 min, dried, and baked in a vacuum oven for 2 hr
at 80°C. Prior to incubation with an anti-alkyldeoxy-
nucleoside Mab (first antibody), the NC filters are treated
for2hrwithphosphate-buffered saline(PBS)containing
0.1-0.5% casein (Sigma, St. Louis, Mo, USA) and 0.1%
deoxycholate, to prevent nonspecific Mab-binding. The
NC filters are then incubated for 1 hr in the same type
ofsolution as above in a heat-sealed plastic bag with an
Mab solution containing 15 pug of Mab per milliliter and
per 10-15 cm2 of NC ifiter area (first antibody). Mab
concentrations are determined by RIA titration (31).
Table 1. Detection limit and sensitivity of the competitive RIA using various anti-alkyldeoxynucleoside Mab.
Sensitivity of RIA (lowest
Designation of Mab Alkyldeoxy- Mab affinity Detection limit of measurable alkyldeoxynucleoside/
(isotype) nucleoside constants, L/mole RIA, fmolea deoxynucleoside molar ratio in DNA)"
ER-7 (lgGj) 06-MedGuo 1.0 x 109 250 1.9 x 10-7
ER-6 (lgG2b) 06-EtdGuo 2.0 x 1010 40 3.1 x 10-8
ER-11 06-BudGuo 9.1 x 109 60 4.6 x 10-8
ER-1005 (lgGu) O'-iProdGuo 1.2 x 1010 50 3.8 x 10-8
EM-051 (lgGu) 04-MedThd 4.0 x 10' 7040 3.9 x 10-6
ER-01 (lgG?,) 04-EtdThd 1.3 x 109 240 1.3 x 10-7
aStandard conditions for RIA: 100 ,uL assay volume; 3 x 10-1" M [3H]-labeled tracer; 50% inhibition oftracer-antibody binding (ITAB).
bAnalysis by RIA of the respective alkyldeoxynucleoside fraction only, separated by HPLC from a sample of 2 mg of DNA enzymatically
hydrolyzed to monodeoxynucleosides. Values calculated for RIA conditions as described in footnote a, assuming a content of 6.5 x 10-7 mole
of dGuo and 9.0 x 10-7 mole of dThd per mg of DNA. In practice, a hydrolyzate of 5 x 2 mg of DNA must be separated by HPLC for more
precise analysis by RIA (duplicate assay, and a dilution series of five samples).
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FIGURE 1. Separation by reverse-phase HPLC of 06-alkyldeoxy-
guanosine and 04-alkyldeoxythymidine from the same sample of
DNA enzymatically hydrolyzed to monodeoxynucleosides (al-
kyl methyl, ethyl),prior to analysis by competitive RIA. HPLC
fractions collected for RIA analysis following concentration by
evaporation, are indicated in the graph. Caffeine was added to the
DNA hydrolyzate as a marker. Due to the absence ofcross-reac-
tants in the final RIA test samples, the detection limit ofthe RIA
is improved considerably (see Table 1). HPLC conditions: column,
2 x 25 cm (Merck Lichrosorb RP,8', 10 ,um); flow rate, 1 mL/min;
temperature, 37°C; buffer A (start): 0.2 M NH4-acetate, pH 5.0,
25% MeOH; buffer B: MeOH. Elution program: (i) 0%B-15%B,
25 min; (ii) 100% B-15% B; 10 min.
Malignant Neuroectodermal BDIX-Rat Cell Lines
Induced by EtNU
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FIGURE 2. Malignant neuroectodermal rat cell lines induced by in
vivo exposure of fetal BDIX-rat brain cells to the N-nitroso car-
cinogen N-ethyl-N-nitrosourea (EtNU) (33,34). Enzymatic re-
moval from DNA ofthe alkylation product 06-ethyldeoxyguanosine
(06-EtdGuo), as measured by competitive RIA using Mab ER-6
(Table 1). From Rajewsky and Huh (35) with permission of the
publishers.
AfterextensivewashinginPBS supplemented with0.16
M NaCl and 0.1% Triton X-100 (with several buffer
changes), the NC filters carrying specifically bound first
antibody are again sealedinplastic bags containingPBS
supplemented with 0.1-0.5% casein and 0.1% deoxy-
cholate and reacted for 1 hr with an 1"I-labeled second
antibody specific fortheimmunoglobulin (Ig) ofthe first
Mab. Thereafter, the NC filters are washed, dried, and
exposed to Kodak X-Omat AR film. Alternatively, the
degree ofbinding of the antialkyldeoxynucleoside Mab
to the DNA on the NC filters may be determined by a
three-step procedure resulting in a colored precipitate.
Following incubation with the first Mab, excess anti-
body is removed by extensive washing in PBS supple-
mented with 0.16 M NaCl (PBS-NaCl). The NC filters
are then incubated for30minatroomtemperature with
a biotinylated second antibody specific for the first Mab
(Vectastain; biotinylated rabbit anti-rat IgG Ig; Camon,
Wiesbaden, Germany; diluted 1:200 in PBS-NaCI),
washed three times for 10 min in PBS-NaCl, and once
for 5 min in Tris-NaCl buffer (0.1 M Tris-HCI, pH 7.5,
1.0 M NaCl, 2-mM MgCl2, 0.05% Triton X-100). There-
after, the NC filters are incubated for 30 min at room
temperature with a complex ofavidin and biotinylated,
polymerized alkaline phosphatase (40), and washed in
Tris-NaCl buffer four times for 5 min at room temper-
ature. The NC-filters are then incubated in a solution
of nitro blue tetrazolium (0.33 mg/mL) and 5-bromo-4-
chloro-3-indolyl phosphate (0.17 mg/mL) in 0.1 M Tris-
HCI, 0.1 M NaCl, 5 mM MgCl2, pH 9.5 (40). Color de-
velopment is terminated by a final wash in PBS con-
taining 10 mM EDTA. Prior to densitometric evaluation,
the NC filters are stored wet in heat-sealed plastic bags
(26).
Theextraordinary sensitivity ofthe ISB derives from
the fact that the measured signals (color development
on the NC filter or silver grains on the sensitive X-ray
film) are further amplified with the time of incubation
or exposure, respectively. A direct comparison of the
ISB with the competitive RIA illustrates the perfor-
mance of the ISB. Thus, the detection limit for O6-
EtdGuo obtained with Mab ER-6 (5,26) in the RIA (40
fmole of 06-EtdGuo at 50% ITAB, Table 1) is reduced
to ¢ 0.3 fmole in the ISB when
- 3 ,ug of DNA are
analyzed per slot. In comparison with the RIA, much
less DNA is required for ISB analysis (e.g., 3 ,ug DNA
for the ISB instead of 100 ,ug DNA for the RIA, of a
DNA sample containing 06-EtdGuo at an 06-EtdGuo/
dGuo molar ratio of -3 x 10-7). As the noncompetitive
ISB does not operate under equilibrium conditions, there
is less influence ofthe antibody affinity constant on the
detection limitincomparison withthecompetitive RIA.
Forexample, thebestoftheanti-(04-EtdThd) Mab, ER-
01 (6) is characterized by an antibody affinity constant
of 1 x 109 L/mole and a detection limit of240 fmole in
the RIA (Table 1). In contrast, the detection limit of
Mab ER-O1 in the ISB (0i:0.1 fmole in a sample of s,3
,ug DNA) is even lower than the ISB-detection limit of
ER-6 for 06-EtdGuo (antibody affinity constant, 2 x
1010 L/mole).
co
.F
a) cr
E
c
U)
c
a
.0
C/)
.0
0
0 .0
.0 LU
I- (0
.0 ~~~~0
6 .0
0 -0 z ~~~~~~~~~~~~~~~LU
10 IV,~~~~~~ 0~~~~~~~~ C.)
10 4)~~~~
01
52MONOCLONAL ANTIBODY-BASED IMMUNOANALYSIS
Immunocytological Analysis (ICA)
The particular advantage of ICA (which also repre-
sents a noncompetitive, solid-phase type of immunoas-
say) lies in the fact that specific alkyldeoxynucleosides
can be detected directly in the genomic DNA of indi-
vidual cells (e.g., in squash preparations ofsmall tissue
samples or in cell culture, in the case of frozen tissue
sections even in cells in their proper histological envi-
ronment). However, compared with the RIA and the
ISB, ICA requires much more sophisticated equipment
and experience (24).
For ICA, cell samples (smears, squash preparations,
cytocentrifuged cell preparations, sections of frozen or
paraffin-embedded tissues) are fixed for 10 min in Car-
noy's ethanol:chloroform:acetic acid (6:3:1), washed in
ethanol, and rehydrated in 2 x SSC (0.3 M NaCl, 0.03
M sodium citrate). After treatment with RNase A (EC
3.1.4.22; Sigma, Munchen, Germany; 200 ,ug/mL of2 x
SSC) and Ti RNase (EC 3.1.4.8; Boehringer; 50 units/
mL of2 x SSC) for 1 hr at 370C, the cell preparations
are washed in 0.15 M NaCl, and nuclear DNA is de-
natured by dipping the slides into 0.07 M NaOH for
exactly 4 min at room temperature. This is immediately
followed by a wash in cold TEA buffer (10 mM trieth-
anolamine, 150 mM NaCl, 100 mM MgCl2, 10 mM EDTA,
0.02% NaN3, pH 7.2; 10 min), and layering of the an-
tibody solution onto the preparations. For visualization
of O-EtdGuo in cellular DNA by direct immunoflu-
orescence, cell preparations are incubated overnight at
40C with a tetramethylrhodamine isothiocyanate
(TRITC)-labeled Mab (ER-14) (24,41) at an Mab con-
centration of 20 ,ug/mL of TEA buffer supplemented
with 4% polyethylene glycol 4000 (Roth) and the Fc-
fragment of rat IgG (0.25 mg/mL). Subsequently, the
cell preparations are washed for 2 x 10 min in TEA
buffer and embedded in 10% (w/v) Elvanol (DuPont,
Niagara Falls, NY) dissolved in PBS and 30% glycerol,
(pH 8), containing p-phenylenediamine (1 mg/mL). For
quantitation of nuclear fluorescence, fluorescence im-
ages are amplified by an image intensifier and fed into
an image analysis system via a high sensitivity televi-
sion camera (24,41).
The detection limit of ICA is defined by the number
of modified deoxynucleosides detectable in the nuclear
DNA of single cells, and is strongly dependent on the
nonspecific "background binding" produced by indivi-
dual Mab. Only selected Mab from ourcollection ofanti-
alkyldeoxynucleoside Mab can be used for ICA; the ma-
jority ofthe Mab either do not stain well, or they pro-
duce nonspecific staining, probably due to stickiness of
the Mab molecules, or due to their binding to cellular
epitopes not identical with the antigenic determinant
on the particular DNA alkylation product to be de-
tected. At present, -700 O6-EtdGuo residues per dip-
loid genome (corresponding to an 06-EtdGuo/dGuo molar
ratio in DNAof-3 x 10-7) canbedetected usingTRITC-
labeled Mab ER-14 (24,41). Due toits limitationby non-
specific antibody binding, ICA is a particular domain of
the ultrapure Mab. In view of the obvious importance
of ICA for the demonstration of specific DNA adducts
of carcinogens and mutagens, as well as chemothera-
peutic agents in individual (e.g., human) cells, and for
comparative analyses of the DNA repair capacity of
phenotypically differing cells (including the assessment
ofintercellular and inter-individual variability), contin-
uedefforts are necessarytofurtheroptimize ICAmeth-
odology and to expand its range to a larger number of
structurally modified DNA constituents.
Immuno-Electron Microscopy (IEM)
With the use of immuno-electron microscopy (IEM)
in conjunction with a protein-free DNA spreadingtech-
nique (25), specific alkyldeoxynucleosides can be visu-
alized in double-stranded DNA molecules via Mab-
binding sites. In a typical preparation for IEM ofDNA
containing 06-EtdGuo, and anti-(O6-EtdGuo) Mab (e.g.,
Mab ER-6; 5, 25; 80 ,ug/mL (is incubated with DNA (50
,ug/mL)inTMS-buffer(10mMtriethanolamine, 100mM
Mg-acetate, 150mM NaCl, 10 mM EDTA, 0.02% NaN3,
pH 7.2). In the case of Mab ER-6, incubation is for 30
min at 37°C. Glutardialdehyde may then be added to
give a final concentration of0.01%. Thereafter, control
DNA, or ethylated DNA carrying bound Mab, is sep-
arated from unreacted Mab molecules by gel ifitration
on Sephacryl S-1000 (Pharmacia, Uppsala, Sweden) in
TMS-buffer. Aliquots of DNA-containing fractions are
diluted with 10 mM Tris-HCl, 150 mM NaCl, 1 mM
EDTA (pH 7.2) to give a concentration of 5-10 ,ug of
DNA/mL and immediately mounted onto freshly cleaved
mica as described (25). The mica supports with the ad-
herent material are washed in H20 for 1 min, stained
for 30 sec in a 1% aqueous solution of uranyl acetate,
and washed again in H20. For subsequent analysis by
transmission electron microscopy, the DNA prepara-
tions are shadowed with Pt/C at 70C, and the replicas
are enforced with carbon conditioned by NaCl. Using
IEM, a highly nonrandom formation of 06-EtdGuo has
recently been demonstrated in chromosomal DNA of
fetal rat brain isolated 1 hr after transplacental expo-
sure to EtNU in vivo (25). IEM can thus be applied to
localize possible "hot spots" of specific structural mod-
ifications caused by DNA-reactive agents within DNA
strands (genes) of known nucleotide sequence.
In summary, various types ofimmunoassays, in con-
junction with the use of monoclonal antibodies, have
opened new possibilities for the sensitive detection,
quantitation, and visualization of low levels of specific
structural modifications in cellular DNA. The new im-
munoanalytical methodology may be of particular rel-
evance for research on molecular mechanisms of
carcinogenesis and mutagenesis (including DNA re-
pair), on the interactions of chemotherapeutic agents
with the DNA of cancer cells, and for cancer
epidemiology.
Research supported by the Deutsche Forschungsmeinschaft (SFB
102/A9), by the Commission of the European Communities (ENV-
544-D[B]), and by the Wilhelm and Maria Meyenburg Stiftung. The
5354 ADAMKIEWICZ ET AL.
authors are grateful to Ms. U. Schauer, Miss I. Schmidt, Miss I.
Spratte, and Ms. G. Jost for expert technical assistance, and to Miss
J. Leyh for typing the manuscript.
REFERENCES
1. Reddy, M. V., Gupta, R. C., Randerath, E., and Randerath, K.
32P-postlabeling test for covalent DNA binding of chemicals in
vivo: application to a variety of aromatic carcinogens and meth-
ylating agents. Carcinogenesis 5: 231-242 (1984).
2. Lo, K. M., Franklin, W. A., Lippke, J. A., Henner, W. D., and
Haseltine, W. A. New methods for the detection ofDNA damage
to human cellular DNA by environmental carcinogens and anti-
tumor drugs. In: Indicators ofGenotoxic Exposure (Banbury Re-
port 13) (B. A. Bridges, B. E. Butterworth, and I. B. Weinstein,
Eds.), Cold SpringHarborLaboratory, Cold SpringHarbor, NY,
1982, pp. 253-263.
3. Baird, W. M. The use ofradioactive carcinogens to detect DNA
modification. In: Chemical Carcinogens and DNA (P. L. Grover,
Ed.), CRC Press, Boca Raton, FL, 1979, pp. 59-83.
4. Beranek, D. T., Weis, C. C., and Swenson, D. H. A comprehen-
sive quantitativeanalysis ofmethylated andethylated DNAusing
high pressure liquid chromatography. Carcinogenesis 1: 595-606
(1980).
5. Rajewsky, M. F., Miller, R., Adamkiewicz, J., and Drosdziok,
W. Immunological detection and quantification of DNA compo-
nents structurally modified by alkylating carcinogens (ethylnitro-
sourea). In: Carcinogenesis: Fundamental Mechanisms and
Environmental Effects (B. Pullman, P. 0. P. Ts'oand H. Gelboin,
Eds.), Reidel, Dordrecht, 1980, pp. 207-218.
6. Adamkiewicz, J., Drosdziok, W., Eberhardt, W., Langenberg,
U., and Rajewsky, M. F. High-affinitymonoclonalantibodies spe-
cific for DNA components structurally modified by alkylating
agents. In: Indicators of Genotoxic Exposure (Banbury Report
13) (B. A. Bridges, B. E. Butterworth, and I. B. Weinstein,
Eds.), Cold Spring Harbor Laboratory, Cold SpringHarbor, NY,
1982, pp. 265-276.
7. Groopman, J. D., Haugen, A., Goodrich, G. R., Wogan, G. N.,
andHarris, C. C. QuantitationofaflatoxinB,-modified DNAusing
monoclonal antibodies. Cancer Res. 42: 3120-3124 (1982).
8. Saffhill, R., Strickland, P. T., and Boyle, J. M. Sensitive radioim-
munoassays for 06-n-butyldeoxyguanosine, 02-n-butylthymidine
and 04-n-butylthymidine. Carcinogenesis 3: 547-552 (1982).
9. Hertzog, P. J., Smith, J. R. L., and Garner, R. C. Production of
monoclonal antibodies to guanine imidazole ring-opened aflatoxin
B, DNA, the persistent DNA adduct in vivo. Carcinogenesis 3:
825-828 (1982).
10. Wild, C. P., Smart, G., Saffhill, R., and Boyle, J. M. Radioim-
munoassayof06-methyldeoxyguanosine inDNA ofcellsalkylated
in vitro and in vivo. Carcinogenesis 4: 1605-1609 (1983).
11. Miller, R., and Rajewsky, M. F. Antibodies specific for DNA
components structurally modified by chemical carcinogens. J.
Cancer Res. Clin. Oncol. 102: 99-113 (1981).
12. Poirier, M. C. Antibodies to carcinogen-DNA adducts. J. Natl.
Cancer Inst. 67: 515-519 (1981).
13. Poirier, M. C., Yuspa, S. H., Weinstein, I. B., and Blobstein, S.
Detection ofcarcinogen-DNA adducts byradioimmunoassay. Na-
ture 270: 185-188 (1977).
14. Leng, M., Sage, E., Fuchs, R. P. P., and Daune, M. P. Antibodies
to DNA modified by the carcinogen N-acetoxy-N-2-acetylami-
nofluorene. FEBS Letters 92: 207-210 (1978).
15. Hsu, I. C., Poirier, M. C., Yuspa, S. H., Grunberger, D., Wein-
stein, I. B., Yolken, R. H., and Harris, C. C. Measurement of
benzo(a)pyrene-DNA adducts by enzyme immunoassays and ra-
dioimmunoassay. Cancer Res. 41: 1091-1095 (1981).
16. Van der Laken, C. J., Hagenaars, A. M., Hermsen, G., Kriek,
E., Kuipers, A. J., Nagel, J., Scherer, E., andWelling, M. Mea-
surement of 06-ethyldeoxyguanosine and N-(deoxyguanosine-8-
yl)-N-acetyl-2-aminofluorene in DNA by high-sensitive enzyme
immunoassays. Carcinogenesis 3: 569-572 (1982).
17. Muller, R., Adamkiewicz, J., and Rajewsky, M. F. Immunological
detection and quantification of carcinogen-modified DNA com-
ponents. In: Host Factors in Human Carcinogenesis (H. Bartsch
and B. Armstrong, Eds.), IARC Scientific Publications No. 39,
International Agency for Research on Cancer, Lyon, 1982, pp.
463-479.
18. Rajewsky, M. F., Adamkiewicz, J., Drosdziok, W., Eberhardt,
W., and Langenberg, U. High-affinity monoclonal antibodies di-
rected against DNA components structurally modified by alkyl-
ating N-nitroso compounds. In: Application ofBiological Markers
to Carcinogen Testing (H. A. Milman and S. Sell, Eds.), Plenum
Press, New York, 1983, pp. 373-385.
19. Adamkiewicz, J., Ahrens, O., and Rajewsky, M. F. High-affinity
monoclonal antibodies specific for deoxynucleosides structurally
modified by alkylating agents: applications for immunoanalysis.
In: Biological Dosimetry (W. G. Eisert and M. C. Mendelsohn,
Eds.), Springer, Berlin-Heidelberg, 1984, pp. 325-334.
20. Adamkiewicz, J., Ahrens, O., Eberle, G., Nehls, P., and Ra-
jewsky, M. F. Monoclonal antibody-based immunoanalytical
methods for detection of carcinogen-modified DNA components.
In: Cyclic Nucleic Acid Adducts in Carcinogenesis/Mutagenesis.
IARC Scientific Publications, International Agency for Research
on Cancer, Lyon, 1985, in press.
21. Muller, R., and Rajewsky, M. F. Sensitive radioimmunoassay for
detection of 06-ethyldeoxyguanosine in DNA exposed to the car-
cinogen ethylnitrosourea in vivo or in vitro. Z. Naturforsch. 33c:
897-901 (1978).
22. Muller, R., and Rajewsky, M. F. Immunological quantification
by high affinity antibodies of 06-ethyldeoxyguanosine in DNA
exposed toN-ethyl-N-nitrosourea. Cancer Res. 40:887-896 (1980).
23. Muller, R., and Rajewsky, M. F. Enzymatic removal of06-ethyl-
guanine versus stability of 04-ethylthymine in the DNA of rat
tissues exposed to the carcinogen ethylnitrosourea: possible in-
terference of guanine-O6 alkylation with 5-cytosine methylation
in the DNA ofreplicating target cells. Z. Naturforsch. 38c: 1023-
1029 (1983).
24. Adamkiewicz, J., Ahrens, O., Huh, N., and Rajewsky, M. F.
Quantitation of alkyl-deoxynucleosides in the DNA of individual
cells by high-affinity monoclonal antibodies and electronically in-
tensified, direct immunofluorescence. J. Cancer Res. Clin. Oncol.
105: A15 (1983).
25. Nehls, P., Rajewsky, M. F., Spiess, E., and Werner, D. Highly
sensitive sitesforguanine-O6 ethylationinratbrain DNAexposed
to N-ethyl-N-nitrosourea in vivo. EMBO J. 3: 327-332 (1984).
26. Nehls, P., Adamkiewicz, J., and Rajewsky, M. F. Immuno-slot-
blot: a highly sensitive immunoassay for the quantitation of car-
cinogen-modified nucleosides in DNA. J. CancerRes. Clin. Oncol.
108: 23-29 (1984).
27. Erlanger, B. F., and Beiser, S. M. Antibodies specific for ribo-
nucleosides and ribonucleotides and their reaction with DNA.
Proc. Natl. Acad. Sci. (U.S.) 52: 68-74 (1964).
28. Druckrey, H. Genotypes and phenotypes often inbred strains of
BD-rats. Arzneim.-Forsch. 21: 1274-1278 (1971).
29. Kearney, J. F., Radbruch, A., Liesegang, B., and Rajewsky, K.
A new mouse myeloma cell line that has lost immunoglobulin
expression but permits the construction ofantibody-secreting hy-
brid cell lines. J. Immunol. 123: 1548-1550 (1979).
30. Galfre, G., Milstein, C., and Wright, B. Rat x rat hybrid mye-
lomas and a monoclonal anti-Fd portion of mouse lgG. Nature
277: 131-133 (1979).
31. Muller, R. Calculation ofaverage antibody affinity in anti-hapten
sera from data obtained by competitive radioimmunoassay. J.
Immunol. Meth. 34: 345-352 (1980).
32. Farr, R. S. A quantitative immunochemical measure of the pri-
mary interaction between I BSA and antibody. J. Infect. Dis.
103: 239-262 (1958).
33. Laerum, 0. D., and Rajewsky, M. F. Neoplastic transformation
of fetal rat brain cells in culture following exposure to ethylni-
trosourea in vivo. J. Natl. Cancer Inst. 55: 1177-1187 (1975).
34. Rajewsky, M. F., Augenlicht, L. H., Biessmann, H., Goth, R.,
Hulser, D. F., Laerum, 0. D., and Lomakina, L. Y. Nervous
system-specific carcinogenesis by ethylnitrosourea in the rat: mo-
lecular and cellular aspects. In: Origins ofHuman Cancer (H. H.
Hiatt, J. D. Watson, andJ. A. Winsten, Eds.), Cold Spring Har-
bor Laboratory, Cold Spring Harbor, NY, 1977, pp. 709-726.MONOCLONAL ANTIBODY-BASED IMMUNOANALYSIS 55
35. Rajewsky, M. F., and Huh, N. Molecularandcellularmechanisms
underlyingineffective cancerchemotherapy. RecentResults Can-
cer Res.96: 18-29 (1984).
36. Huh, N., and Rajewsky, M. F. Enzymatic climination of06-ethyl-
guanine and stability of04-ethylthymine inthe DNA ofmalignant
neuroectodermal cell lines exposed to N-ethyl-N-nitrosourea in
culture. Submitted.
37. Goth, R., and Rajewsky, M. F. Persistence of 06-ethylguanine
in rat brain DNA: correlation with nervous system-specific car-
cinogenesis by ethylnitrosourea. Proc. Natl. Acad. Sci. (U.S.) 71:
639-643 (1974).
38. Laerum, 0. D., Rajewsky, M. F., Schachner, M., Stavrou, D.,
Haglid, K. G., and Haugen, A. Phenotypic properties of neo-
plastic cell lines developed from fetal rat brain in culture after
exposure to ethylnitrosourea in vivo. Z. Krebsforsch. 89: 273-
295 (1977).
39. Muller, R., and Rajewsky, M. F. Elimination of06-ethylguanine
from the DNA of brain, liver, and other rat tissues exposed to
ethylnitrosourea at different stages of prenatal development.
Cancer Res. 43: 2897-2904 (1983).
40. Leary, J. J., Brigati, D. J., and Ward, D. C. Rapid and sensitive
colorimetric method for visualizing biotin-labeled DNA probes to
DNA or RNA immobilized to nitrocellulose: bio-blots. Proc. Natl.
Acad. Sci. (U.S.) 80: 4045-4049 (1983).
41. Adamkiewicz, J., and Rajewsky, M. F. In preparation.